Consolidated Statements of Income - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
[1] | Sep. 30, 2023 |
Sep. 30, 2022 |
[1] | |||
| Revenues | ||||||||
| Premiums | $ 10,998 | $ 9,586 | $ 33,062 | $ 30,368 | ||||
| Net investment income | 321 | 204 | 876 | 943 | ||||
| TOTAL REVENUES | 49,048 | 45,281 | 144,151 | 134,765 | | |||
| Benefits and expenses | ||||||||
| Pharmacy and other service costs | 33,639 | 31,777 | 98,540 | 92,740 | ||||
| Medical costs and other benefit expenses | 8,927 | 7,751 | 27,007 | 24,215 | ||||
| Selling, general and administrative expenses | 3,788 | 3,151 | 10,760 | 9,690 | ||||
| Amortization of acquired intangible assets | 454 | 460 | 1,368 | 1,419 | ||||
| TOTAL BENEFITS AND EXPENSES | 46,808 | 43,139 | 137,675 | 128,064 | | |||
| Income from operations | 2,240 | 2,142 | 6,476 | 6,701 | | |||
| Interest expense and other | (365) | (304) | (1,086) | (904) | | |||
| (Loss) gain on sale of businesses | (21) | 1,735 | (21) | 1,735 | | |||
| Net realized investment losses | (14) | (82) | (44) | (493) | | |||
| Total Other Income Expenses | -400.0 | 1349.0 | -1151.0 | 338.0 | 0 | |
||
| Income before income taxes | 1,840 | 3,491 | 5,325 | 7,039 | | | ||
| TOTAL INCOME TAXES | 391 | 713 | 1,060 | 1,479 | | |||
| Net income | 1,449 | 2,778 | 4,265 | 5,560 | | |||
| Less: Net income attributable to noncontrolling interests | 41 | 21 | 130 | 49 | ||||
| SHAREHOLDERS' NET INCOME | $ 1,408 | $ 2,757 | $ 4,135 | $ 5,511 | ||||
| Shareholders' net income per share | ||||||||
| Basic (in dollars per share) | $ 4.79 | $ 9.07 | $ 14.03 | $ 17.64 | ||||
| Diluted (in dollars per share) | $ 4.74 | $ 8.97 | $ 13.89 | $ 17.46 | ||||
| Pharmacy revenues | ||||||||
| Revenues | ||||||||
| Revenues | $ 34,531 | $ 32,762 | $ 100,639 | $ 95,431 | ||||
| Fees and other revenues | ||||||||
| Revenues | ||||||||
| Revenues | $ 3,198 | $ 2,729 | $ 9,574 | $ 8,023 | ||||
| ||||||||
| X | ||||||||||
- Definition The net realized gains or (losses) on investments during the period, including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity. No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|